Objectives The benefit of autologous stem cell transplantation (ASCT) in the treatment of light chain (AL) amyloidosis requires re-evaluation in the modern era. This retrospective case-matched study compares ASCT to bortezomib for the treatment of patients with AL amyloidosis.Sharpley, Faye A.Man...
Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation. V Sanchorawala...
Accurate classification is essential as treatment varies widely depending on the type of amyloid present. While the pathogenesis of amyloidosis is well characterized, there is little information about the types of amyloid that involve the skin, and whether these types produce histologically recognizable ...
Common toxicity criteria: version 2.0, an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000; 47: 13–47. Article CAS Google Scholar Comenzo RL, Wally J, Kica G et al. Clonal immunoglobulin light chain variable ...
Accurate classification is essential as treatment varies widely depending on the type of amyloid present. While the pathogenesis of amyloidosis is well characterized, there is little information about the types of amyloid that involve the skin, and whether these types produce histologically recognizable ...